BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 14681943)

  • 1. Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion.
    Knapik JA; Murphy WM
    Cancer; 2003 Dec; 99(6):352-6. PubMed ID: 14681943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.
    Lin DW; Herr HW; Dalbagni G
    J Urol; 2003 Mar; 169(3):961-3. PubMed ID: 12576822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring.
    Nieder AM; Sved PD; Gomez P; Kim SS; Manoharan M; Soloway MS
    Urology; 2004 Nov; 64(5):950-4. PubMed ID: 15533484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urethral tumor recurrence following radical cystoprostatectomy--an indication for primary cystoprostato-urethrectomy?].
    Gökcebay E; Riedmiller H; Stöckle M; Hohenfellner R
    Urologe A; 1989 Jul; 28(4):199-203. PubMed ID: 2763395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prepubic urethrectomy during radical cystoprostatectomy.
    Joniau S; Shabana W; Verlinde B; Van Poppel H
    Eur Urol; 2007 Apr; 51(4):915-21. PubMed ID: 17069962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urethral recurrence after cysto-prostatectomy for bladder tumor].
    Robert M; Burgel JS; Serre I; Guiter J; Grasset D
    Prog Urol; 1996; 6(4):558-63. PubMed ID: 8924933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for one-stage and delayed urethrectomy after radical cystectomy in patients with invasive cancer of the urinary bladder].
    Darenkov SP; Gorilovskiĭ ML; Chernyshev IV; Akmatov NA
    Urologiia; 2003; (5):5-8. PubMed ID: 14658263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
    Stein JP; Penson DF; Wu SD; Skinner DG
    J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment for urethral recurrence after ileal neobladder reconstruction in patients with bladder cancer.
    Yoshida K; Nishiyama H; Kinoshita H; Matsuda T; Ogawa O
    BJU Int; 2006 Nov; 98(5):1008-11. PubMed ID: 17034603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens.
    Stein JP; Cote RJ; Freeman JA; Esrig D; Elmajian DA; Groshen S; Skinner EC; Boyd SD; Lieskovsky G; Skinner DG
    J Urol; 1995 Oct; 154(4):1329-33. PubMed ID: 7658531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.
    Donat SM; Wei DC; McGuire MS; Herr HW
    J Urol; 2001 May; 165(5):1580-4. PubMed ID: 11342921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of urethral recurrence after orthotopic urinary diversion.
    Taylor JM; Spiess PE; Kassouf W; Munsell MF; Kamat AM; Dinney CP; Grossman HB; Pisters LL
    BJU Int; 2010 Jul; 106(1):56-61. PubMed ID: 20002676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.
    Weizer AZ; Shah RB; Lee CT; Gilbert SM; Daignault S; Montie JE; Wood DP
    Urol Oncol; 2007; 25(6):460-4. PubMed ID: 18047952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary management of the urethra in patients after radical cystectomy for bladder cancer.
    Clark PE; Hall MC
    Urol Clin North Am; 2005 May; 32(2):199-206. PubMed ID: 15862617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.
    Caraway NP; Khanna A; Payne L; Kamat AM; Katz RL
    Cancer; 2007 Oct; 111(5):323-9. PubMed ID: 17721991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis and treatment of urethral recurrence after radical cystectomy.
    Sherwood JB; Sagalowsky AI
    Urol Oncol; 2006; 24(4):356-61. PubMed ID: 16818191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
    Hemal AK; Kolla SB
    J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.